Hsbc Holdings PLC lifted its stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 47.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 25,502 shares of the business services provider's stock after acquiring an additional 8,167 shares during the quarter. Hsbc Holdings PLC owned 0.05% of Exponent worth $2,270,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of EXPO. Raymond James Financial Inc. purchased a new position in Exponent in the fourth quarter valued at $55,131,000. Norges Bank purchased a new position in shares of Exponent in the 4th quarter valued at about $52,381,000. Resona Asset Management Co. Ltd. purchased a new position in Exponent in the fourth quarter valued at about $38,538,000. JPMorgan Chase & Co. raised its stake in shares of Exponent by 63.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider's stock worth $72,701,000 after buying an additional 245,086 shares during the last quarter. Finally, Barclays PLC increased its position in Exponent by 88.5% during the fourth quarter. Barclays PLC now owns 181,921 shares of the business services provider's stock worth $16,209,000 after buying an additional 85,395 shares in the last quarter. Hedge funds and other institutional investors own 92.37% of the company's stock.
Insiders Place Their Bets
In other Exponent news, VP Richard Reiss sold 1,736 shares of Exponent stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total value of $149,174.48. Following the completion of the transaction, the vice president now owns 1,800 shares in the company, valued at approximately $154,674. The trade was a 49.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 2.10% of the company's stock.
Exponent Trading Down 0.8 %
Shares of NASDAQ EXPO traded down $0.63 on Monday, reaching $76.15. 211,505 shares of the company traded hands, compared to its average volume of 241,584. Exponent, Inc. has a fifty-two week low of $73.37 and a fifty-two week high of $115.75. The company has a 50 day moving average of $80.59 and a 200 day moving average of $89.50. The stock has a market capitalization of $3.87 billion, a PE ratio of 35.92 and a beta of 0.84.
Exponent (NASDAQ:EXPO - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The business services provider reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. The firm had revenue of $137.44 million for the quarter, compared to analyst estimates of $134.63 million. Exponent had a net margin of 19.52% and a return on equity of 27.27%. The firm's revenue was up .2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.59 EPS. As a group, research analysts expect that Exponent, Inc. will post 1.98 earnings per share for the current year.
Exponent Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Investors of record on Friday, June 6th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.58%. The ex-dividend date of this dividend is Friday, June 6th. Exponent's payout ratio is presently 56.60%.
Exponent Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
See Also

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.